SIR 2016: Improving patient care through innovation, research and technology

January 22, 2016

Fairfax, Va. -- Registration is now open for the Society of Interventional Radiology's (SIR's) Annual Scientific Meeting, the world's most comprehensive interventional radiology meeting dedicated to improving patient care through research in image-guided, minimally invasive medicine. This year's meeting takes place April 2, 2016 through April 7, 2016 at the Vancouver Convention Centre in Vancouver, British Columbia.

Expected to attract more than 5,000 doctors, researchers and allied health professionals, SIR 2016 features more than 250 scientific presentations and 125 companies unveiling their latest IR medical devices, products and services. Attendees will be equipped with current data on breakthrough treatments for numerous diseases and conditions including stroke, cancer, uterine fibroids, and venous and peripheral arterial disease.

"Many of the IR procedures that we perform today were first introduced in the scientific sessions at past SIR annual meetings," said Brian Funaki, MD, FSIR, the meeting's scientific program chair. "During this year's meeting, we will present the most current critical information about clinical trials, technical innovations and the basic science at the foundation of our specialty."

In addition to learning about life-changing scientific findings and treatment innovations, this year's meeting will also offer the opportunity to collaborate with other disciplines through the "SIR Meets" gatherings, which feature multidisciplinary interactions with other specialties. Meanwhile, activities with international IR societies will explore innovation and lessons from around the world.

SIR 2016's general sessions feature the IR's top thought-leaders on major, often controversial, issues. This year's Dr. Charles T. Dotter Lecture, presented by Scott O. Trerotola, MD, FSIR, will explore how embracing competition can better IR patient care by spurring innovation.

"The ultimate goal of SIR 2016 is to provide inspiration and information about innovations that have the power to improve the care that interventional radiologists deliver," said Funaki, who is a professor of radiology and the vascular and interventional radiology section chief at the University of Chicago School of Medicine.

More information may be found at Early bird registration ends Jan. 29, 2016 and the advance registration deadline is Feb. 19. To register for the meeting, visit
About the Society of Interventional RadiologyThe Society of Interventional Radiology is a nonprofit, professional medical society representing more than 5,600 practicing interventional radiology physicians, scientists and clinical associates, dedicated to improving patient care through the limitless potential of image-guided therapies. SIR's members work in a variety of settings and at different professional levels--from medical students and residents to university faculty and private practice physicians. Visit

Society of Interventional Radiology

Related Clinical Trials Articles from Brightsurf:

Nearly 1 in 5 cancer patients less likely to enroll in clinical trials during pandemic
A significant portion of cancer patients may be less likely to enroll in a clinical trial due to the ongoing coronavirus pandemic.

COVID-19 clinical trials lack diversity
Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials.

Why we should trust registered clinical trials
In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study brings good news about the credibility of registered clinical trials.

Inclusion of children in clinical trials of treatments for COVID-19
This Viewpoint discusses the exclusion of children from coronavirus disease 2019 (COVID-19) clinical trials and why that could harm treatment options for children.

Review evaluates how AI could boost the success of clinical trials
In a review publishing July 17, 2019 in the journal Trends in Pharmacological Sciences, researchers examined how artificial intelligence (AI) could affect drug development in the coming decade.

Kidney patients are neglected in clinical trials
The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients.

Clinical trials beginning for possible preeclampsia treatment
For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia -- a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main causes of death in both mothers and unborn babies.

Underenrollment in clinical trials: Patients not the problem
The authors of the study published this month in the Journal of Clinical Oncology investigated why many cancer clinical trials fail to enroll enough patients.

When designing clinical trials for huntington's disease, first ask the experts
Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments.

New ALS therapy in clinical trials
New research led by Washington University School of Medicine in St.

Read More: Clinical Trials News and Clinical Trials Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to